Is Glucose Control Important for Prevention of Cardiovascular Disease in Diabetes?

Meta-Analysis of Effect of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Risk in Type 2 Diabetes Mellitus

(2012) Harshal R. Patil et al.   AMERICAN JOURNAL OF CARDIOLOGY

Incretin-based therapies and cardiovascular risk

(2012) Edoardo Mannucci et al.   CURRENT MEDICAL RESEARCH AND OPINION

Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials

(2012) M. Monami et al.   DIABETES OBESITY & METABOLISM

Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2012) S. E. Inzucchi et al.   DIABETOLOGIA

Hypoglycemia and Risk of Death in Critically Ill Patients

(2012)   NEW ENGLAND JOURNAL OF MEDICINE

Insulin Resistance, Hyperglycemia, and Atherosclerosis

(2011) Karin E. Bornfeldt et al.   Cell Metabolism

High-density lipoprotein-cholesterol and not HbA1c was directly related to cardiovascular outcome in PROactive

(2011) E. Ferrannini et al.   DIABETES OBESITY & METABOLISM

Cardiovascular Disease in Diabetes: Where Does Glucose Fit In?

(2011) Jane E. B. Reusch et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials

(2010) C. Lamanna et al.   DIABETES OBESITY & METABOLISM

Glucagon-like peptide-1-based therapies and cardiovascular disease: looking beyond glycaemic control

(2010) P. Anagnostis et al.   DIABETES OBESITY & METABOLISM

The A1C and ABCD of glycaemia management in type 2 diabetes: a physician's personalized approach

(2010) Paolo Pozzilli et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Insulin use and increased risk of mortality in type 2 diabetes: a cohort study

(2009) J.-M. Gamble et al.   DIABETES OBESITY & METABOLISM

Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study

(2009) E. L. M. Barr et al.   DIABETOLOGIA

A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease

(2009)   NEW ENGLAND JOURNAL OF MEDICINE

Prevention of cardiovascular disease through glycemic control in type 2 diabetes: A meta-analysis of randomized clinical trials

(2009) E. Mannucci et al.   NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES

Cardioprotective and Vasodilatory Actions of Glucagon-Like Peptide 1 Receptor Are Mediated Through Both Glucagon-Like Peptide 1 Receptor–Dependent and –Independent Pathways

(2008) Kiwon Ban et al.   CIRCULATION

Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association

(2008) J. S. Skyler et al.   DIABETES CARE

Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies

(2008) Theodore Mazzone et al.   LANCET

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Intensive Glucose Lowering in Type 2 Diabetes

(2008)   NEW ENGLAND JOURNAL OF MEDICINE

Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes

(2008) Peter Gæde et al.   NEW ENGLAND JOURNAL OF MEDICINE

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes

(2008) William Duckworth et al.   NEW ENGLAND JOURNAL OF MEDICINE